- Home
- NBTX vs PMTS Comparison
NBTX vs PMTS Comparison
Compare NBTX & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- PMTS
- Stock Information
- Founded
- NBTX 2003
- PMTS 2007
- Country
- NBTX France
- PMTS United States
- Employees
- NBTX N/A
- PMTS N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- PMTS Finance Companies
- Sector
- NBTX Health Care
- PMTS Finance
- Exchange
- NBTX Nasdaq
- PMTS Nasdaq
- Market Cap
- NBTX 211.9M
- PMTS 203.1M
- IPO Year
- NBTX 2020
- PMTS 2015
- Fundamental
- Price
- NBTX $9.85
- PMTS $15.64
- Analyst Decision
- NBTX Strong Buy
- PMTS Strong Buy
- Analyst Count
- NBTX 1
- PMTS 4
- Target Price
- NBTX $8.00
- PMTS $34.00
- AVG Volume (30 Days)
- NBTX 15.0K
- PMTS 87.5K
- Earning Date
- NBTX 09-17-2025
- PMTS 08-08-2025
- Dividend Yield
- NBTX N/A
- PMTS N/A
- EPS Growth
- NBTX N/A
- PMTS N/A
- EPS
- NBTX N/A
- PMTS 1.11
- Revenue
- NBTX N/A
- PMTS $502,361,000.00
- Revenue This Year
- NBTX N/A
- PMTS $14.61
- Revenue Next Year
- NBTX $74.67
- PMTS $12.49
- P/E Ratio
- NBTX N/A
- PMTS $13.89
- Revenue Growth
- NBTX N/A
- PMTS 14.31
- 52 Week Low
- NBTX $2.76
- PMTS $12.52
- 52 Week High
- NBTX $10.59
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- NBTX 75.73
- PMTS 37.90
- Support Level
- NBTX $8.20
- PMTS $14.68
- Resistance Level
- NBTX $10.59
- PMTS $16.16
- Average True Range (ATR)
- NBTX 0.51
- PMTS 1.01
- MACD
- NBTX 0.18
- PMTS 0.10
- Stochastic Oscillator
- NBTX 79.95
- PMTS 49.68
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.